The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Induction TPF followed by chemoradiation or radiotherapy-cetuximab in nonresectable advanced head and neck squamous cell carcinoma: A retrospective study in 164 patients.
Delphine Borchiellini
No relevant relationships to disclose
Charlotte Dupuis
No relevant relationships to disclose
Jocelyn Gal
No relevant relationships to disclose
Benjamin Lallemant
No relevant relationships to disclose
Marc Alfonsi
No relevant relationships to disclose
Karen Benezery
No relevant relationships to disclose
Christian Righini
No relevant relationships to disclose
Bruno Guelfucci
No relevant relationships to disclose
Michel Beltran
No relevant relationships to disclose
Alexandre Bozec
No relevant relationships to disclose
Gilles Poissonnet
No relevant relationships to disclose
Olivier Dassonville
No relevant relationships to disclose
Antoine Giovanni
No relevant relationships to disclose
Francois Morvan
No relevant relationships to disclose
Frederic Peyrade
No relevant relationships to disclose